Covered recipient · General Payments record
ANDRES E CRUZ-INIGO
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,141.86
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,609.61 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,464.62 | 15 |
| Lilly USA, LLC | $120.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.10 | 1 |
| Eli Lilly Export S.A. Puerto Rico Branch | $10.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $101.39 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519958 | CMS |
| ABBVIE INC. | $48.91 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519960 | CMS |
| ABBVIE INC. | $147.22 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519962 | CMS |
| ABBVIE INC. | $2.39 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519964 | CMS |
| ABBVIE INC. | $47.43 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519966 | CMS |
| ABBVIE INC. | $18.34 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519968 | CMS |
| ABBVIE INC. | $117.69 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519970 | CMS |
| ABBVIE INC. | $94.74 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519972 | CMS |
| ABBVIE INC. | $131.80 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519974 | CMS |
| ABBVIE INC. | $147.25 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519976 | CMS |
| ABBVIE INC. | $112.80 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519978 | CMS |
| ABBVIE INC. | $136.94 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519980 | CMS |
| ABBVIE INC. | $134.11 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519982 | CMS |
| ABBVIE INC. | $106.34 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519984 | CMS |
| ABBVIE INC. | $117.27 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103519986 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.10 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101402249 | CMS |
| Eli Lilly Export S.A. Puerto Rico Branch | $10.89 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136037551 | CMS |
| Lilly USA, LLC | $120.00 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136036517 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.